Notes to the financial statements of
Bystronic AG
Principles
General remarks
The financial statements 2022 of Bystronic AG have been prepared in accordance with the provisions of the Swiss Code of Obligations. The significant accounting policies applied but not required by law are described below.
The financial statements were approved for publication by the Board of Directors on February 27, 2023. They are also subject to approval by the General Assembly.
Financial assets
Financial assets consist of investments with a long-term investment purpose. Loans granted in foreign currencies are valued at the current closing rate.
Derivative financial instruments
Foreign exchange hedging transactions are entered into in order to hedge currency risks arising from operating activities. All open derivatives are recognized at fair value as of the balance sheet date and reported gross in the balance sheet under other receivables or other current liabilities. Changes in the value of derivatives used to hedge recognized underlying transactions are recognized in the income statement in the same way as the underlying transaction.
Interest-bearing liabilities
Interest-bearing liabilities are recognized at nominal value.
Treasury shares
Treasury shares are recognized at cost at the time of acquisition. Treasury shares are recognized as a negative item in equity. In the event of subsequent resale, the gain or loss is credited to legal capital reserves.
Share-based compensation
Share-based compensation to members of the Board of Directors is measured at fair value at the grant date and charged to other operating expenses in the period in which the service is rendered.
Disclosures on income statement and balance sheet items
Income
Dividend payments of the subsidiaries are determined depending on retained earnings and capital requirements. Financial income includes interest income on receivables from investments of CHF 6.1 million (previous year: CHF 5.1 million), interest income from third parties of CHF 2.1 million (previous year: 0.9 million). In the prior year, foreign exchange gains on cash and cash equivalents and on receivables from investments of CHF 0.7 million and a gain on marketable securities of CHF 0.2 million was included in the financial income. Other operating income of CHF 0.2 million (previous year: CHF 0.4 million) is related to brokerage fees from insurance companies. The gain from the sale of investments in the previous year of CHF 46.8 million originated from the sale of FoamPartner Switzerland AG of CHF 43.1 million and of Mammut Sports Group AG of CHF 3.7 million.
Expenses
Financial expenses result from interest on liabilities to investments of CHF 0.5 million (previous year: CHF 0.3 million), currency hedging costs (interest differences) of balance sheet items in foreign currencies of CHF 2.4 million (previous year: CHF 2.3 million), commitment fees for bank loans of CHF 0.4 million (previous year: CHF 0.3 million) and negative interest on bank balances of CHF 0.4 million (previous year: CHF 0.3 million) and foreign exchange losses on cash and cash equivalents and on receivables from investments of CHF 0.3 million. Other operating expenses include current administrative costs, project costs, capital taxes and the fees of the Board of Directors amounting to CHF 1.0 million (previous year: CHF 1.2 million).
Current assets
Cash and cash equivalents comprise bank deposits, mostly in Swiss francs. Marketable securities include time deposits in Swiss francs with a remaining maturity of more than 90 days. Other receivables from third parties include recoverable input and withholding taxes as well as taxes at source of CHF 0.3 million (previous year: CHF 0.1 million), balances from foreign exchange hedging transactions with banks of CHF 12.1 million (previous year: CHF 3.5 million) and receivables from social insurances of CHF 0.1 million. In the previous year, a residual purchase price receivable from the sale of FoamPartner Switzerland AG of CHF 10.4 million was included. Other receivables from investments include the credit balances from currency hedging transactions of CHF 0.8 million (previous year: CHF 0.5 million) and other receivables from investments of CHF 0.5 million (previous year: CHF 0.2 million).
Non-current assets
Financial assets consist of investments with a long-term investment purpose. Receivables from investments increased by CHF 31.1 million in the reporting year. Other financial assets from third parties relate to a vendor loan in connection with the sale of Mammut Sports Group AG. Due to a capital repayment, investments decreased by CHF 39.3 million.
Liabilities
Other short-term liabilities mainly include liabilities from currency hedging transactions to banks of CHF 1.8 million (previous year: CHF 2.8 million) and liabilities from currency hedging transactions to group companies of CHF 7.1 million (previous year: CHF 1.1 million).
Equity
The share capital of CHF 4.1 million (previous year: CHF 4.1 million) is divided into 1,827,000 class A registered shares and 1,215,000 class B registered shares. At the end of 2021, the company held 1,815 class A registered shares at an average purchase price of CHF 1,259 each. For the participation program, 1,000 class A registered shares were acquired in the reporting year at an average transaction price of CHF 981 each. The Board of Directors was allocated 377 class A registered shares at an average transaction price of CHF 900 each. Members of the Executive Committee and other members of management were allocated 487 class A registered shares at an average transaction price of CHF 919 each. These costs were invoiced to the group companies with which these persons have an employment relationship. The transaction price corresponded to the market value in each case. As of December 31, 2022, 1,951 class A registered shares are held at an average purchase price of CHF 1,145 each.
Further disclosures
Full-time positions
No employees are employed at Bystronic AG.
Contingent liabilities
CHF 1,000 |
2022 |
|
2021 |
|
|
|
|
|
|
Sureties and guarantee obligations for subsidiaries |
105,119 |
|
64,356 |
|
Effective obligations |
17,884 |
|
12,279 |
|
|
|
|
|
|
Investments
The investments are listed in note 4.3 of the consolidated financial statements. The voting shares correspond to the capital shares.
Significant shareholders
Auer, Schmidheiny and Spoerry shareholder group |
2022 |
|
2021 |
|
|
|
|
|
|
Capital rights |
28.9% |
|
28.9% |
|
Voting rights |
51.0% |
|
51.0% |
|
|
|
|
|
|
The Auer, Schmidheiny and Spoerry shareholder group consists of Dr. Matthias Auer, Martin Byland, Rudolf Byland, Christina Byland, Caliza Holding AG, Marina Marti-Auer, Marina Milz, Adrian and Annemarie Herzig-Büchler, Sven and Rosmarie Mumenthaler-Sigrist, Jacob Schmidheiny, Margrit Schmidheiny, Felix Schmidheiny, Helen Schmidheiny, Kathrin Spoerry, Christina Spoerry, Heinrich Spoerry-Niggli, Lotti Spoerry and Robert F. Spoerry.
Shareholdings held by members of the Board of Directors and Executive Committee and by related persons
Number |
Class A registered shares 12/31/2022 |
|
Class A registered shares 12/31/2021 |
|
Class B registered shares 12/31/2022 |
|
Class B registered shares 12/31/2021 |
|
|
|
|
|
|
|
|
|
|
Board of Directors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dr. Heinz O. Baumgartner, Chairman |
40 |
|
|
|
|
|
|
|
Dr. Roland Abt, Member |
398 |
|
358 |
|
|
|
|
|
Dr. Matthias Auer, Member |
22,611 |
|
22,571 |
|
1,008 |
|
1,008 |
|
Inge Delobelle, Member |
|
|
|
|
|
|
|
|
Urs Riedener, Member |
398 |
|
358 |
|
|
|
|
|
Jacob Schmidheiny, Member |
129,510 |
|
129,470 |
|
6,032 |
|
6,032 |
|
Robert F. Spoerry, Member |
7,545 |
|
7,230 |
|
148 |
|
148 |
|
|
|
|
|
|
|
|
|
|
Dr. Matthias Auer, Jacob Schmidheiny and Robert F. Spoerry hold further registered shares under a shareholder agreement within the Auer, Schmidheiny and Spoerry shareholder group.
Number |
Class A registered shares 12/31/2022 |
|
Class A registered shares 12/31/2021 |
|
Class B registered shares 12/31/2022 |
|
Class B registered shares 12/31/2021 |
|
|
|
|
|
|
|
|
|
|
Executive Committee |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alex Waser (CEO) |
1,248 |
|
1,054 |
|
|
|
|
|
Beat Neukom (CFO) |
|
|
|
|
|
|
|
|
Johan Elster |
69 |
|
30 |
|
|
|
|
|
Robert St. Aubin |
|
|
|
|
|
|
|
|
Norbert Seo |
|
|
|
|
|
|
|
|
Dr. Song You |
|
|
|
|
|
|
|
|
Eamon Doherty |
33 |
|
|
|
|
|
|
|
Alberto Martinez |
32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation paid to members of the Board of Directors and Executive Committee is shown in the compensation report.
Share-based compensation
The basic compensation of the members of the Board of Directors is paid in cash and in shares (approx. 50% each) with a four-year vesting period. Neither discounts nor performance components are taken into account for the calculation of the Board of Directors’ share allocation. The average share price over three months from November 1st to January 31st of the respective term of office is used.
In 2022, a total of 377 class A registered shares were allocated to the Board of Directors for the previous year. The valuation was made using a share price of CHF 900 and amounted to CHF 0.3 million. For the share-based compensation component for the reporting year, an expense accrual in the amount of CHF 0.3 million (previous year: CHF 0.3 million) is included in other operating expenses.
Events after the balance sheet date
There are no events after the balance sheet date that require a value adjustment to the assets and liabilities recognized in the balance sheet or that require disclosure.